z-logo
Premium
The P‐Stereocontrolled Synthesis of PO/PS‐Chimeric Oligonucleotides by Incorporation of Dinucleoside Phosphorothioates Bearing an O ‐4‐Nitrophenyl Phosphorothioate Protecting Group
Author(s) -
Wozniak Lucyna A.,
Góra Marcin,
BukowieckaMatusiak Małgorzata,
Mourgues Sophie,
Pratviel Geneviève,
Meunier Bernard,
Stec Wojciech J.
Publication year - 2005
Publication title -
european journal of organic chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.825
H-Index - 155
eISSN - 1099-0690
pISSN - 1434-193X
DOI - 10.1002/ejoc.200400910
Subject(s) - chemistry , diastereomer , oligonucleotide , stereochemistry , aryl , stereospecificity , protecting group , chirality (physics) , exonuclease , chiral auxiliary , dna , biochemistry , organic chemistry , catalysis , enantioselective synthesis , alkyl , nambu–jona lasinio model , chiral symmetry breaking , physics , quantum mechanics , dna polymerase , quark
The synthesis of protected model dinucleoside (3',5')‐ O ‐aryl phosphorothioates, their separation into pure diastereomers, and their successful incorporation into oligonucleotides followed by stereospecific deprotection of the O ‐aryl phosphorothioate function with oximate ion (inversion) enables the preparation of chimeric PO/PS‐oligonucleotides with a predetermined sense of P ‐chirality at each internucleotide phosphorothioate position. The absolute configuration at the phosphorus of the internucleotide O ‐aryl phosphorothioate in “dimeric building blocks” has been assigned. The 3'‐terminal S P ‐phosphorothioate linkages effectively protect such chimeric constructs from degradation by human plasma exonuclease (© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2005)

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom